A Phase I, Single-Dose, Gamma Scintigraphy Study to Assess the Pulmonary Deposition of Technetium-99m Radiolabelled Budesonide, Glycopyrronium and Formoterol Fumarate MDI Following a Maximal Breath-Hold of up to 10 seconds in Patients with Moderate to Severe/Very Severe Chronic Obstructive Pulmonary Disease (COPD).
Back to Resource Center